Migraine induction with calcitonin gene-related peptide in patients from erenumab trials

BACKGROUND: Migraine prevention with erenumab and migraine induction by calcitonin gene-related peptide (CGRP) both carry notable individual variance. We wanted to explore a possible association between individual efficacy of anti-CGRP treatment and susceptibility to migraine induction by CGRP. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Casper Emil, Younis, Samaira, Deen, Marie, Khan, Sabrina, Ghanizada, Hashmat, Ashina, Messoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755614/
https://www.ncbi.nlm.nih.gov/pubmed/30409109
http://dx.doi.org/10.1186/s10194-018-0927-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755614/
https://www.ncbi.nlm.nih.gov/pubmed/30409109
http://dx.doi.org/10.1186/s10194-018-0927-2

Ejemplares similares